Bronchodilators in subjects with asthma-related comorbidities.
Asthma
Comorbidities
Muscarinic agonists
Xanthines
β(2)-agonists
Journal
Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
12
12
2018
revised:
29
03
2019
accepted:
01
04
2019
entrez:
4
5
2019
pubmed:
3
5
2019
medline:
7
5
2020
Statut:
ppublish
Résumé
Asthma is often associated with different comorbidities such as cardiovascular diseases, depression, diabetes mellitus, dyslipidaemia, osteoporosis, rhinosinusitis and mainly gastro-oesophageal reflux disease and allergic rhinitis. Although bronchodilators play an important role in the treatment of asthma, there is no overall description of their impact on comorbid asthma, regardless of whether favourable or negative. This narrative review examines the potential effects of bronchodilators on comorbidities of asthma.
Identifiants
pubmed: 31047116
pii: S0954-6111(19)30098-8
doi: 10.1016/j.rmed.2019.04.001
pii:
doi:
Substances chimiques
Bronchodilator Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
43-48Informations de copyright
Copyright © 2019. Published by Elsevier Ltd.